Bio Break: The Power of Continuous Analyte Monitoring
In this episode of Bio Break, StarFish Medical experts Joris and Nick dive into the transformative concept of Continuous Analyte Monitoring (CxM) and its growing role in wearable medical devices. They discuss the value of tracking metabolic markers over time, as opposed to relying on static time-point measurements, and how this approach enhances precision in both diagnostics and treatment.
The discussion highlights the evolution of continuous monitoring, starting with the gold standard of blood testing. While blood samples provide accurate results, their invasive nature and impracticality for frequent testing have driven innovation in non-invasive or minimally invasive techniques. For instance, wearable devices now use sensors with flexible needles or interstitial fluid measurements to monitor markers like glucose continuously.
Nick shares fascinating insights from his past work monitoring stress responses in animals, where cortisol levels were measured using both blood samples and innovative hair analysis techniques. He emphasizes the importance of timing in traditional testing, as data can fluctuate significantly depending on the time of day or external stressors. This variability underlines the immense value of continuous monitoring, which provides consistent, real-time data and eliminates the need for rigid sampling schedules.
Key takeaways from the episode include:
- Continuous Monitoring Advantages: The ability to track trends and patterns over time, offering deeper insights into a patient’s health.
- Wearable Innovations: How cutting-edge devices measure biomarkers like glucose or cortisol through interstitial fluid, enhancing patient convenience and compliance.
- Precision in Data: Continuous tracking minimizes variability caused by time-of-day effects or environmental stressors, improving diagnostic and therapeutic accuracy.
This episode highlights how CxM technology is shaping the future of personalized healthcare by offering real-time, actionable insights. Whether you’re a developer, healthcare professional, or simply curious about wearable medical devices, this episode provides valuable knowledge about the impact of continuous monitoring on patient outcomes.
The Power of Continuous Analyte Monitoring
Related Resources
StarFish developed the Industrial Design from concept to production engineering for the ALLY™ Adaptive Cataract Treatment System, the first platform to combine world class imaging and next generation dual-pulse femtosecond laser in a single system.
Nexus is a next-generation integrated ultrasonic surgical platform that combines all the features of Misonix’s existing solutions into a single fully integrated platform that will also serve to power future solutions.
StarFish worked with Freedom to develop their Spherical Shock Unit component of the ShockWave™ prosthetic foot which provides ultimate vertical shock absorption at heel strike easing stress on the residual limb for a more natural gait.
Learn the Basics of Wearable Medical Device Adhesives including DO’s and Don’ts in our comprehensive overview.
Related Resources
Every phase of a device’s life cycle involves different people with distinct needs—from clinicians and patients to service technicians and regulatory bodies.
Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.
Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.
You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.